The divestment was part of a $2.5 billion divestment required by South Africa's competition committee.
"Bayer will continue working with regulators globally with a view to receiving approval of the proposed transaction by the end of 2017," the company said.
Bayer and Monsanto have yet to request regulatory approval in Europe, and the merger is currently under review in the U.S.
Jim Cramer and Real Money columnists discuss the latest from President Donald Trump and the GOP efforts to repeal and replace the Affordable Care Act. See which stocks they are discussing and get hisinsights or analysis with a free trial subscription to Real Money.